Differences in the effects of zolpidem and diazepam on recurrent inhibition and long-term potentiation in rat hippocampal slices

Neuroscience Letters

Volumn 245, Issue 2, 1998, Pages 77-80

  Higashima, Masato ^a   Kinoshita, Hiroya ^a   Koshino, Yoshifumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Aminobutyric acid receptor; Benzodiazepine; Diazepam; Hippocampus; Long term potentiation; Recurrent inhibition; Zolpidem

Indexed keywords

DIAZEPAM; ZOLPIDEM;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; DIAZEPAM; ELECTRIC STIMULATION; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; NEURAL INHIBITION; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 0032478508     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00178-5     Document Type: Article

References (18)

1. Adamec R.E., McNaughton B., Racine R., Livingston K.E. Effects of diazepam on hippocampal excitability in the rat: action in the dentate area. Epilepsia. 22:1981;205-215.
2. 3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors. Eur. J. Pharmacol. 130:1986;257-263.
3. Balkin T.J., O'Donnell V.M., Wesensten N., McCann U., Belenky G. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam. Psychopharmacology. 107:1992;83-88.
4. 3H]flumazenil binding in the rat central nervous system. J. Pharmacol. Exp. Ther. 263:1992;884-896.
5. Clarke P.R.F., Eccersley P.S., Frisby J.P., Thornton J.A. The amnestic effect of diazepam (valium). Br. J. Anaesth. 42:1970;690-697.
6. Chweh A.Y., Lin Y.B., Swinyard W.A. Hypnotic action of benzodiazepines: a possible mechanism. Life Sci. 34:1984;1763-1768.
7. Del Cerro S., Jung M., Lynch G. Benzodiazepines block long-term potentiation in slices of hippocampus and piriform cortex. Neuroscience. 49:1992;1-6.
8. Evans S., Funderburk F.R., Griffiths R.R. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J. Pharmacol. Exp. Ther. 255:1990;1246-1255.
9. Higashima M., Kinoshita H., Yamaguchi N., Koshino Y. Differences in enhancing effects of zolpidem and benzodiazepine drugs on recurrent inhibition in rat hippocampal slices. Psychopharmacology. 131:1997;394-398.
10. Langer S.Z., Arbilla S. Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes. Pharmacol. Biochem. Behav. 29:1988;763-766.
11. MacDonald R., Barker J.L. Benzodiazepines specifically modulate GABA-mediated postsynaptic inhibition in cultured mammalian neurons. Nature. 271:1978;563-564.
12. A receptor subtypes immunopurified from rat brain with α subunit-specific antibodies have unique pharmacological properties. Neuron. 7:1991;667-676.
13. A-benzodiazepine receptors produced in transfected cells. Science. 245:1989;1389-1392.
14. 5-subunit creates novel type II benzodiazepine receptor pharmacology. J. Neurochem. 54:1990;1802-1804.
15. A/benzodiazepine receptor complex in the rat nervous system. J. Neurochem. 58:1992;485-493.
16. Schultz L.M. GABAergic inhibitory processes and hippocampal long-term potentiation. Neuroscientist. 3:1997;226-236.
17. Spencer W.A., Kandel E.R. Hippocampal neuron responses to selective activation of recurrent collaterals of hippocampofugal axons. Exp. Neurol. 4:1961;149-161.
18. Study R.E., Barker J.L. Diazepam and (-)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of γ-aminobutyric acid responses in cultured spinal cord neurons. Proc. Natl. Acad. Sci. USA. 78:1981;7180-7184.